Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Current API product portfolio   

Carbamazepine

Specification:
  • Ph.Eur.
chemical name: 5H-dibenz[b,f]azepine-5-carboxamide
molecular formula: C15H12N2O
structural formula: structural formula
molecular weight: 236.3
CAS Registery number: 298-46-4

General information:

Appearance: white or almost white, crystalline powder.
Solubility: very slightly soluble in water, freely soluble in methylene chloride, sparingly soluble in acetone and alcohol.
It shows polymorphism; the acceptable crystalline form corresponds to carbamazepine CRS.

TESTS REQUIERMENTS METHODS
Identification:

a) melting point

b) IR spectrum


189°C to 193°C

corresponds to reference substance spectrum
Ph. Eur.
Acidity or alkalinity acc. to Ph. Eur. acc. to Ph. Eur. Ph. Eur.
Related substances (HPLC):

- 10,11-dihydrocarbamazepine (impurity A)

- iminodibenzyl (impurity E)

- other single impurity

- sum of impurities


not more than 0.1%


not more than 0.1%

not more than 0.10%

not more than 0.5%
Ph. Eur.
Chlorides not more than 140 ppm Ph. Eur.
Heavy metals not more than 20 ppm Ph. Eur.
Loss on drying not more than 0.5% Ph. Eur.
Sulphated ash not more than 0.1% Ph. Eur.
Content of carbamazepine calculate on dried substance 98.0% to 102.0% Ph. Eur.
Residual solvents:

- methanol

- toluen

- ethanol*


not more than 1000 ppm

not more than 500 ppm

not more than 1000 ppm
POLPHARMA
* if used in production « back to API list

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo